Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 2 - The Untold Story

Even mild COVID raises the chance of heart attack and stroke. What to know about the risks ahead

A concerning report recently published in Nature Medicine suggests even a mild case of COVID can increase the long-term risks of serious cardiovascular diseases such as stroke, heart attack and heart failure. The study highlights our limited understanding of the full consequences of COVID infection and the long-term impact of…

The Conversation

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

Benzinga

Monkeypox virus mutating quickly warn experts as symptoms change

The findings come from two separate studies with both comparing today's cases with those from the past

Wales Online

From analysis to the latest developments in health,
read the most diverse news in one place.

Brain networks and nicotine addiction

A study of patients who quit smoking spontaneously reveals brain networks that are associated with alcohol and other forms of addiction

The Hindu

Long COVID affects more older adults; shots don't prevent it

Research in U.S. veterans provides fresh evidence that long COVID-19 can happen even after breakthrough infections following vaccination

The Independent UK

Could psilocybin mushrooms help with depression?

A small study suggests that psilocybin could increase brain activity in people with depression, writes Andrew Jacobs

The Independent UK

Magic Mushrooms Are More Effective Than Antidepressants In Treating Depression, New Study Shows

A recent study led by Imperial College London’s Centre for Psychedelic Research found that psilocybin could increase neuroplasticity in cases of treatment-resistant depression (TRD), even more than traditional antidepressants, such as selective serotonin reuptake inhibitors (SSRIs). The results of the study were reported in the journal Nature Medicine under the name…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Is Wall Street The Next Stop For Psychedelics? Investing In The Psychedelic Medicine Sector

This article was originally published on Psychedelic Spotlight and appears here with permission. Elemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future of the psychedelics market in this guest blog for Psychedelic Spotlight. The use of psychedelic drugs to treat mental health conditions is…

Benzinga

Warning issued for Covid sufferers as link to 20 dangerous conditions found in new study

Research published in Nature Medicine shows that anyone who has tested positive for Covid could be at a higher risk of 20 conditions, including a stroke, heart failure and cardiac arrest

Daily Mirror

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

US Food and Drug Administration

Psychedelic Spotlight

29 stories

Medicines and Healthcare products Regulatory Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.